The Valley Desk

ArticleJournal of medicinal chemistryPublished

Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Journal of medicinal chemistry
Published
Subject terms
Brain; Animals; Humans; Parkinson Disease; Macrocyclic Compounds; Protein Kinase Inhibitors; Structure-Activity Relationship; Drug Discovery; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
PubMed ID
41906303
Added to directory
Source checked

Report a correction or request removal